Article
Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell Carcinoma…
bioRxiv · 2020 · Ziad Bakouny
Key facts
| Title | Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell Carcinoma Reveals Determinants of Poor Prognosis and Response to Immune Checkpoint Inhibitors |
|---|---|
| First author | Ziad Bakouny |
| Journal | bioRxiv |
| Published | May 30, 2020 |
| DOI | 10.1101/2020.05.28.121806 |
| Devices mentioned | K042572, K770467, K780428, K791373, K801244, K820613, K820614, K820942, K852441, K854177, K854178, K854179 and 9 more |
| Product codes mentioned | CCX, EXJ, FEG, FRL, KNT, KOX, PFT, CDT, CEO, CFE, CGA, CGX and 12 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1